Roche's bond issue paves the way for Genentech takeover
This article was originally published in Scrip
Executive Summary
Roche has sold $16 billion in debt to help finance its $42 billion hostile pursuit of Genentech. The proceeds will help Roche finance the buyout of the 44% of the biotech that it does not already own.